A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of SC injections of 3 regimens of adalimumab vs. placebo in the
change in post-bronchodilator FEV1 from Baseline to Week 16 when used in the treatment of
refractory asthma.